Cargando…

Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care

The objective was to investigate type, frequency and result of clinical outcomes used in studies to assess the effect of clinical pharmacy interventions in inpatient care. The literature search using Pubmed.gov was performed for the period up to 2013 using the search phrases: “Intervention(s)” and “...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjeldsen, Lene Juel, Olesen, Charlotte, Hansen, Merete Kjær, Nielsen, Trine Rune Høgh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597153/
https://www.ncbi.nlm.nih.gov/pubmed/28970440
http://dx.doi.org/10.3390/pharmacy5020028
_version_ 1783263658165403648
author Kjeldsen, Lene Juel
Olesen, Charlotte
Hansen, Merete Kjær
Nielsen, Trine Rune Høgh
author_facet Kjeldsen, Lene Juel
Olesen, Charlotte
Hansen, Merete Kjær
Nielsen, Trine Rune Høgh
author_sort Kjeldsen, Lene Juel
collection PubMed
description The objective was to investigate type, frequency and result of clinical outcomes used in studies to assess the effect of clinical pharmacy interventions in inpatient care. The literature search using Pubmed.gov was performed for the period up to 2013 using the search phrases: “Intervention(s)” and “pharmacist(s)” and “controlled” and “outcome(s)” or “effect(s)”. Primary research studies in English of controlled, clinical pharmacy intervention studies, including outcome evaluation, were selected. Titles, abstracts and full-text papers were assessed individually by two reviewers, and inclusion was determined by consensus. In total, 37 publications were included in the review. The publications presented similar intervention elements but differed in study design. A large variety of outcome measures (135) had been used to evaluate the effect of the interventions; most frequently clinical measures/assessments by physician and health care service use. No apparent pattern was established among primary outcome measures with significant effect in favour of the intervention, but positive effect was most frequently related to studies that included power calculations and sufficient inclusion of patients (73% vs. 25%). This review emphasizes the importance of considering the relevance of outcomes selected to assess clinical pharmacy interventions and the importance of conducting a proper power calculation.
format Online
Article
Text
id pubmed-5597153
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-55971532017-09-29 Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care Kjeldsen, Lene Juel Olesen, Charlotte Hansen, Merete Kjær Nielsen, Trine Rune Høgh Pharmacy (Basel) Article The objective was to investigate type, frequency and result of clinical outcomes used in studies to assess the effect of clinical pharmacy interventions in inpatient care. The literature search using Pubmed.gov was performed for the period up to 2013 using the search phrases: “Intervention(s)” and “pharmacist(s)” and “controlled” and “outcome(s)” or “effect(s)”. Primary research studies in English of controlled, clinical pharmacy intervention studies, including outcome evaluation, were selected. Titles, abstracts and full-text papers were assessed individually by two reviewers, and inclusion was determined by consensus. In total, 37 publications were included in the review. The publications presented similar intervention elements but differed in study design. A large variety of outcome measures (135) had been used to evaluate the effect of the interventions; most frequently clinical measures/assessments by physician and health care service use. No apparent pattern was established among primary outcome measures with significant effect in favour of the intervention, but positive effect was most frequently related to studies that included power calculations and sufficient inclusion of patients (73% vs. 25%). This review emphasizes the importance of considering the relevance of outcomes selected to assess clinical pharmacy interventions and the importance of conducting a proper power calculation. MDPI 2017-05-20 /pmc/articles/PMC5597153/ /pubmed/28970440 http://dx.doi.org/10.3390/pharmacy5020028 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kjeldsen, Lene Juel
Olesen, Charlotte
Hansen, Merete Kjær
Nielsen, Trine Rune Høgh
Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care
title Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care
title_full Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care
title_fullStr Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care
title_full_unstemmed Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care
title_short Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care
title_sort clinical outcomes used in clinical pharmacy intervention studies in secondary care
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597153/
https://www.ncbi.nlm.nih.gov/pubmed/28970440
http://dx.doi.org/10.3390/pharmacy5020028
work_keys_str_mv AT kjeldsenlenejuel clinicaloutcomesusedinclinicalpharmacyinterventionstudiesinsecondarycare
AT olesencharlotte clinicaloutcomesusedinclinicalpharmacyinterventionstudiesinsecondarycare
AT hansenmeretekjær clinicaloutcomesusedinclinicalpharmacyinterventionstudiesinsecondarycare
AT nielsentrinerunehøgh clinicaloutcomesusedinclinicalpharmacyinterventionstudiesinsecondarycare